- Entry
- $1.90
- Final
- $1.90 +0.0%
- Target
- $25.00
- Score
- +0.00
In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on aTyr Pharma with a price target of $25.00. Derek Archila has given his Buy rating due to a combination of factors related to aTyr Pharma’s promising drug candidate, efzofitimod. The upcoming Phase 3 trial results for efzofitimod in treating pulmonary sarcoidosis are anticipated to be a significant catalyst for the company’s stock. Archila believes that the market is currently undervaluing the potential success of this …
— ORIGINAL POST ·
I’ll Take It!✅
· r/CountryDumb
· Jul 1, 2025